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EVALUATING THE EFFECTS OF E-CIGARETTE SMOKE AGAINST 
CIGARETTE SMOKE ON LUNG HEALTH 




Electronic Nicotine Delivery Systems (ENDS) are methods of delivering nicotine without 
combustion, which happens in cigarettes. These devices consist of a heating element, a 
battery, and a tank which stores eliquid. Over the years these devices have become more 
powerful, and capable of increased delivery of nicotine. There is a large variety of flavors 
and devices, which causes trouble for standardized studies. These devices were created to 
help cigarette users quit smoking; however, they are associated with significant dual use. 
ENDS produce lower levels of most toxic chemicals when compared to cigarettes, and 
significantly increased levels when compared to not smoking. Newer generation ENDS 
have capabilities of producing levels of reactive oxygen species and carbonyl compounds 
at levels similar to cigarettes. ENDS use has detrimental effects on the genome, immune 
system, and lung function due to exposure from these chemicals. These effects are at 
lower levels when compared to cigarette use. Chronic ENDS use has been associated 
with chronic obstructive pulmonary disorder (COPD), with an even higher association 
with dual use. ENDS use also causes DNA adduct formation, and activates protein 
kinases, nicotine acetylcholine receptors and other pathways for lung cancer as cigarette 
use. The full health effects of ENDS use are still unknown, from the currents studies it is 
clear that its use is not without harm.  
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CHAPTER 1 INTRODUCTION 
Cigarette smoking in America is the leading cause of preventable death (CDC 
2020). In 2019, 14 percent of the population smoked cigarettes (CDC 2020). Combustion 
of cigarettes creates a smoke that is then inhaled and absorbed providing the stimulant 
effects from nicotine. This combustion creates toxic byproducts that also get absorbed 
causing harmful side effects.  Electronic cigarettes were first introduced by a Chinese 
pharmacist as a method to deliver nicotine to smokers while attempting to minimize the 
other toxic byproducts from the combustion of cigarettes (Huang et al 2018, Besaratinia 
& Tommasi, 2014, Rahman et al 2014).  The design was simple; a pod that stored the 
liquid, usually nicotine and some humectants, atomizers, or a heating element to vaporize 
the liquid into an aerosol that can be inhaled, and a battery to power the device (Williams 
et al 2019). Through successive generations, these electronic nicotine delivery systems 
(ENDS) have undergone numerous modifications, in size, power, as well as the 
composition of the liquids they vaporize.  
As of now, there are five generations of these devices. The first generation called 
a “cig a like” had a simple design with no variable settings and were made to be 
discarded after use (Miyashita et al 2020). The second generation added a battery that 
was rechargeable, a button to turn the device on, and a refillable tank (Miyashita et al 
2020). The third-generation devices nicknamed mods allowed users to swap batteries 
allowing for customizable voltage up to 8V (Miyashita et al 2020). The fourth generation 
added advanced batteries that allowed for sub-Ohm resistance and greater control of the 
voltage and temperature of heating (Miyashita et al 2020). The lower resistance at any 
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given voltage delivers significantly increased levels of toxicants like carbonyl 
compounds, ROS, and nicotine (Chaumont et al 2019). Human bronchial epithelial cells 
experienced cytotoxicity with sub-ohm vaping when compared to regular vaping and 
three-day exposure to sub-ohm vape aerosol decreased the viable cells by over 50% 
(Noel et al 2020). The increase in voltage, variable temperatures, and lower resistance 
allows for increased delivery of the aerosol, especially for the third and fourth 
generations (Miyashita et al 2020). The fifth generation ENDS called “pods” is a redesign 
that removes customizability of the previous generations but allows increased delivery of 
nicotine utilizing nicotine salts (Miyashita et al 2020, Pinkston et al 2020). 
In addition to the technology of the ENDS, the liquid inside has also been 
modified throughout the years. The liquid (eliquid) inside consists of nicotine, a 
humectant, and a flavoring agent. There are as many as 8000 flavors available each with 
its own properties (Raj et al 2020). As a result of the many combinations and flavors of 
the ENDS adolescent use has grown exponentially Cherian et al 2020). In 2017 12 
percent of children under 18 were using ENDS and in 2018, that number rose to 28% 
(Cherian et al 2020). Enticing flavors such as mango and strawberry, large variations in 
size, and a notion that these devices are safe to use have made ENDS very popular with 
this age group (Soneji et al 2019, El-Khoury Lesueur et al 2018).  
The first site of interaction in the human body with all these foreign substances in 
the lungs. The lungs are a vital organ that conduct gas exchange which is necessary for 
human life. The recent epidemic of E-Cigarette or Vaping Related Acute Lung Injury 
(EVALI) with more than 2800 individuals hospitalized due to direct ENDS use illustrates 
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the need for a closer understanding of the true health effects of ENDS (Jonas et al 2020). 
The large variety in flavoring and type of devices available makes it difficult for 
standardized studies of these devices. Yet these studies provide insight into the numerous 
health effects that electronic cigarettes use can have. To better understand the health 
effects of ENDS, use on the lungs, this review will focus on the acute and chronic effects 
of electronic cigarette use on the lungs in comparison to cigarette smoking and never 
users.  
 
Constituents of ENDS  
 The sections below will outline the constituents of eliquid: solvent, nicotine, and 
flavoring agents.  
 
Solvent 
Nicotine delivered by the ENDS is dissolved in either propylene glycol (PG) 
and/or vegetable glycerin (VG). These solvents also act as humectants. Humectants are 
hygroscopic molecules that form hydrogen bonds with water molecules and keep the 
aerosol moist. PG and VG are generally recognized as safe by the FDA for ingestion, but 
their respiratory effects are uncertain (Traboulsi et al 2020). PG and VG are known upper 
airway irritants (Chaumont et al 2020). During the heating process to create the ENDS 
aerosol (evap) the temperatures of the device can reach 350°C (Wang et al 2017). At 
these and lower temperatures the solvents breakdown due to thermal degradation into 
reactive carbonyl compounds (Wang et al 2017). PG and VG break down into 
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formaldehyde and acetaldehyde, while at temperatures higher than 220°C VG also forms 
acrolein. Acrolein and formaldehyde are deemed group I carcinogenic compounds by the 
International Agency for Research on Cancer (IARC) and acetaldehyde is classified as a 
group 2B possibly carcinogenic compound (Canistro et al 2017). Formaldehyde is a 
known airway irritant and can impair pulmonary function (Merecz-Sadowska et al 2020). 
Acrolein causes inflammation and increases reactive oxygen species (ROS) production 
and acetaldehyde can form DNA adducts (Merecz-Sadowska et al 2020). VG is 
associated with higher amounts of formaldehyde and acetaldehyde when compared to PG 
(Wang et al 2017).  
Studies show that at 280°C there is 27 times more formaldehyde produced from 
glycerin than from PG, while at 318°C it is only 10x (Wang et al 2017). This means that 
at 215 degrees, a very pleasant temperature for inhalation and well within the range of 
expected heating temperatures for ENDS, the daily dose of formaldehyde would range 
from 105 ug to 117 µg (Wang et al 2017). This is significantly higher than 40 µg, the 
level of formaldehyde that presents no significant risk (Traboulsi 2020). On the other 
hand, 8-10 puffs of a cigarette expose the smoker to 52 µg of formaldehyde (Wang et al 
2017). Worryingly, if the temperature of an ENDS exceeds 280°C 10, 50 ml puffs would 
have similar levels of formaldehyde as cigarette smoke (Wang et al 2017).  
 
Nicotine 
Nicotine exerts its effects by binding to nicotinic acetylcholine receptors on sympathetic 
nerve endings which can result in vascular smooth muscle cells to contract and cause an 
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elevation in blood pressure (Merecz-Sadowska et al 2020). Nicotine can also stimulate 
the contraction of these muscles directly. The effects of nicotine on the human body have 
been studied for a long time with effects ranging from immune system suppression to 
respiratory distress and even cardiovascular distress (Mishra et al 2015). The amount of 
nicotine in eliquids is variable and is generally in line with the manufacturers’ 
specifications (Beauval et al 2017). Nicotine occurs in two forms in eliquids: freebase 
and salts. For liquids that utilize nicotine in its free base form the amount of nicotine can 
vary from 0 - 35 mg/ml while using nicotine salts, the concentration can exceed 60 mg/ml 
(Pinkston et al 2020). At these concentrations, one pod has the equivalent of one pack of 
unlit cigarettes (Pinkston et al 2020). Earlier generation ENDS use corresponded with 
lower levels of nicotine metabolites when compared to cigarette smokers (Goniewicz et 
al 2018). Recently, a study that compared nicotine metabolite levels from three different 
countries found that ENDS users had significantly higher levels of nicotine exposure 
when compared to cigarette smokers (Smith et al 2020). This effect could be due to the 
increased use of nicotine salts and 3rd generation “mod” ENDS devices that have the 
capability of delivering increased nicotine (Smith et al 2020).  
 
Flavoring agents 
There are over 8000 flavoring agents that are commercially available for use in 
eliquids with this list continuously expanding (Raj et al 2020). On average 250 new 
flavors are added each month (Raj et al 2020). Many of the popular flavors have been 
studied but the vast majority remain untested with respect to their respiratory and 
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systemic impacts. Regulation of these flavors is also a problem as the FDA only began 
requiring ENDS companies to submit their liquid for testing in 2022. For example, 
diacetyl which gives a butterscotch flavor has been banned by the FDA and by the EU in 
Europe because inhalation causes bronchitis obliterans colloquially known as popcorn 
lung (Kreis et al 2014). Despite this, Harvard researchers found that 39 out of 51 eliquids 
from 51 companies contained diacetyl (Joseph et al 2016). Other studies have reported 
similar findings (Bhatta et al 2020, Pinkston et al 2020, McConnel et al 2017). Another 
flavoring agent, Cinnamaldehyde which imparts a cinnamon flavor, is known to impair 
mitochondrial function, which leads to an imbalance in ATP production and can decrease 
ciliary beat frequency (Park et al 2019). These two cases represent a small amount of the 
potential side effects these flavoring compounds can have and adds to the complexity of 
studying and understanding the health effects of ENDS.  
 
 SPECIFIC AIMS 
 
 
1. Understand the acute effects on the lung environment from ENDS use. 
2. Compare the effects of ENDS to cigarettes and never users to understand the 
potential impact of ENDS use.  





CHAPTER 2: PUBLISHED STUDIES 
 
Comparison of Components of Evap and Cigarette smoke 
ENDS deliver roughly 6.75x1010 microparticles into the lungs of the user per puff 
(Noel et al 2020). Ultrafine particles, particles smaller than 100 nm, are associated with 
the most severe health outcomes as they can penetrate deep into the respiratory tract 
(Rankin et al 2019). Cigarette smoke delivers around 10 to 40 mg of particulate matter 
having a diameter of less than 1 µm (Traboulsi et al 2020). ENDS, according to a study 
by Rankin, delivered denser vapor that accounts for increased particle amount ranging 
from 7.5 to 9.3 mg/puff, with cigarette smoke only containing 2.2 mg/ puff (Rankin et al 
2019). ENDS overload 25-35% of the daily particle intake of an individual that has does 
not use ENDS or cigarettes (non-smoker), and accounts for 4 times more particle mass 
than similar cigarette smoke (Manigrasso et al 2015, Rankin et al 2019). These UFP are 
associated with a chronic inflammatory state and can lead to diseases such as COPD 
(Traboulsi et al 2020). These particles come from aerosolized components in the eliquid 
that take on different properties once they have been aerosolized. As stated previously 
with solvents, thermal degradation along with other chemical reactions change the 
chemical properties of the starting materials. This is similar to the process that occurs 
during the lighting of a cigarette. In cigarettes the combustion creates a multitude of toxic 
byproducts including volatile organic compounds (VOC), tobacco specific nitrosamines 
(TSNA), and polycyclic aromatic hydrocarbons (PAH) (Goniewicz et al 2018). Many 
studies have found that e cigarette vapor also contains these harmful chemicals. Below is 




Volatile Organic Compounds 
Volatile organic compounds (VOCs) are unstable and possess high vapor 
pressures at room temperature (US EPA 2019). VOCs have a variety of health impacts 
ranging from inflammation to lung cancer and other respiratory diseases (US EPA 2019). 
Multiple studies have found that the major volatile organic compounds found in 
electronic cigarette aerosol were PG, VG, and nicotine by gas chromatography and mass 
spectrometry analysis (Goniewicz et al 2014, Hutzler et al 2014, Leigh et al 2016). Other 
minor VOCs include acrylonitrile, which is a group 1B possible human carcinogen, 
acrolein, methylmercapturic acid (MMA, a methylating agent metabolite), formaldehyde, 
benzene, 2-carbamoylethylmercapturic acid (2-CMMA), an acrylamide (Class 2A IARC) 
2-hydroxypropylmercapturic acid, and (2-HPMA), a propylene oxide (Class 2B IARC) 
metabolite (Smith et al 2020, Helen et al 202).  
  A study that analyzed smokers from three different countries found that 8 out of 
the 14 VOCs tested were significantly lower for ENDS users when compared to cigarette 
smokers (Smith et al 2020). Another study found that levels of acrolein, acrylonitrile, 
acetaldehyde, formaldehyde, and acrylamide were higher for cigarette smokers when 
compared to ENDS users (Goniewicz et al 2020, Beauval et al 2017). A study by 
Goniewicz on toxins in ENDS users found that metabolites of carbon disulfide, toluene, 
and benzene were similar in ENDS users when compared to cigarette smokers 
(Goniewicz et al 2020). Another study by Goniewicz compared the metabolites of these 
toxic compounds for cigarette smokers who switched to ENDS (Goniewicz et al 2017). 
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This switch resulted in a significant decrease for all 8 VOCs and especially for 1,3-
butadiene, benzene, and acrylonitrile (Goniewicz et al 2017). Another study found that of 
their 24 tested VOCs, all except for MMA, were significantly increased in cigarette 
smokers when compared with ENDS users, with the fold difference ranging from 1.31 to 
7.09 for the various VOCs (Helen et al 2020).  
ENDS users had significantly higher serum levels of 2-CMMA, acrylonitrile and 
benzene than never smokers (Helen et al 2020, Goniewicz et al 2018, Smith et al 2020). 
Higher powered ENDS users had increased levels of 2-HPMA, when compared to lower-
powered ENDS users and never smokers (Helen et al 2020).  When the resistance of 
ENDS is dropped from 1.5 ohm to .15 ohm (sub-ohm) a 236-fold increase in acrolein 
levels was observed (Noel et al 2020). Increasing the power with the resistance below 0.5 
ohm causes a significant increase in levels of formaldehyde, acetaldehyde, and other 
carbonyl compounds (Noel et al 2020). 
The trend for all these studies is that VOCs present in evap are usually at levels 
significantly lower than those found in cigarette smoke or for a few at similar levels. 
However, when compared to never smokers they are significantly increased.   
 
Polycyclic Aromatic Hydrocarbons  
Polycyclic aromatic hydrocarbons (PAHs) are ringed organic compounds that are 
produced from the incomplete combustion of organic material and are compounds that 
the IARC classify as possibly, probably, or proven carcinogenic to humans (Traboulsi et 
al 2020). These compounds once inside the body bind to the aryl hydrocarbon receptor 
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which then activate xenobiotic-metabolizing enzymes (XME), like cytochrome P450 1A1 
(CYP1A1) and 1B1 (CYP1B1) (Sun et al 2019). XMEs metabolize these compounds 
which activate them to become genotoxic and cause harm to DNA (Sun et al 2019). The 
levels of these enzymes are tied to these compounds and used by many studies as 
biomarkers for PAHS. PAHs include naphthalene, a compound deemed possibly 
carcinogenic by the IARC and respiratory toxicant, pyrene and benzopyrene the only 
group I classified and proven carcinogenic PAH (Beauval et al 2017, Goniewicz et al 
2017).  
A Study by Beauval found that 10 out of the 16 of the major PAHs found in the 
cigarette smokers were also present in the serum of ENDS users near the limit of 
detection (Beauval et al 2017). The major PAH that was identified was naphthalene at the 
highest concentration of 61.8 ng/mL, (Beauval et al 2017). The PAH concentrations in 
ENDS were significantly decreased when compared to concentrations in cigarettes with 
naphthalene at 136-fold lower (Beauval et al 2017). Benzopyrene was among the 10 
detected in ENDS users (Beauval et al 2017). A study by Goniewiecz found that ENDS 
users had 20% higher concentrations of pyrene when compared to never users 
(Goniewicz et al 2018). ENDS users when compared to cigarette smokers, had 62% and 
47% lower concentrations of naphthalene and pyrene, respectively (Goniewicz et al 
2018). Another study by Goniewicz found that the levels of three out of the 9 PAH 
metabolites studied were decreased for smokers who switched from cigarettes to ENDS 
(Goniewicz et al 2017). The levels of naphthalene, pyrene was not significantly changed 
after the switch (Goniewicz et al 2017).   
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The trend for all these studies is that PAHs present in evap are usually at levels 
significantly lower than those found in cigarette smoke or for a few at similar levels. 
However, when compared to never smokers a few are significantly increased. 
 
Tobacco-Specific Nitrosamines  
Nicotine in the human body is metabolized mainly into cotinine, a nontoxic and 
noncarcinogenic molecule, whose serum levels predict lung cancer risk (Moran et al 
2012, Boetta et al 2006, Hecht et al 2002). Nicotine is also metabolized into nitrosamines, 
toxic and carcinogenic compounds. Nitrosamines can lead to methylation of DNA 
(Bartsch et al 1984). Nitrosamines are further metabolized into nicotine-derived 
nitrosamine ketone (NNK) and N-nitrosonornicotine (NNN); these are both group I 
carcinogens by the IARC (Merecz-Sadowska et al 2020). The serum levels of these 
species and other metabolites allows for an understanding of the levels of nitrosamines 
the human body is exposed to. Some of the major TSNAs are N′-nitrosoanabasine 
(NAB), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL), and N′- 
nitrosoanatabine (NAT)(Merecz-Sadowska et al 2020, Goniewicz et al 2018). NNAL is a 
metabolite of NNK and a known human carcinogen by the IARC (Goniewicz et al 2018). 
These compounds and their metabolites have wide-ranging areas of effect from the 
activation of serine-threonine kinases to DNA adduct formation (Merecz-Sadowska et al 
2020).  
A study by Goniewicz looked at the number of nitrosamines generated by 
cigarettes and ENDS by observing the serum level of NNAL. This study found that 
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ENDS users had 81% more NNAL when compared to never users and 93% less NNAL 
when compared to cigarette smokers (Goniewicz et al 2018). A study of smokers in three 
different countries found that cigarette smokers had significantly higher levels of all 
NAB, NAT, and NNAL when compared to ENDS users and nonsmokers (Smith et al 
2020). While ENDS users only had higher levels of NNAL when compared to non-
smokers (Smith et al 2020). Interestingly among ENDS users, there were variations 
between countries with US and Polish ENDS users having a higher NNAL amount when 
compared with UK ENDS users (Smith et al 2020). A study by Goniewicz which looked 
at the effects of switching from cigs to ENDS found that levels of NNK significantly 
decreased by 64% after two weeks (Goniewicz et al 2017). A longitudinal study by 
Shahbab found that NNAL levels for ENDS were significantly lower than cigarette 
smokers and were comparable with levels of those who were using Nicotine Replacement 
Therapy (Shahbab et al 2017). The trend for all these studies is that TSNAs present in 
evap are at levels significantly lower than those found in cigarette smoke. However, 
when compared to never smokers a few are significantly increased. 
 
Pre-Clinical Studies 
ENDS and cigarette use causes the lungs to encounter the harmful substances discussed 
previously. The damage caused by acute cigarette usage includes inflammation, increased 
fibrinous activity, impaired immune reactivity, impaired lung function, and an altered 
transcriptome (Song et al 2020, Liu et al 2011, Meo et al 2019). Acute ENDS usage also 
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causes similar effects. Below is a discussion of the differences and similarities in acute 
usage of ENDS and cigarette caused damage to the lungs. 
Histological Changes 
Utilizing the hematoxylin and eosin stain, which allows for visualization of cell walls and 
nuclei, a study on rats exposed to ENDS and cigarette vapor found that both groups 
experienced collapse of the lung parenchyma, hyperplasia of type II pneumocytes, and 
increased macrophage count (Wawryk-Gawda et al 2020). Utilizing a trichrome stain 
which allows for visualization of collagen, both experimental groups had increased 
collagen deposition in the septa and interstitial fibrosis (Fig 1) (Wawryk-Gawda et al 
2020). The increased collagen deposition was also seen in a study by Glynos, who 
worked with mice exposed to cigarette and evap (Glynos et al 2018). In a normal lung, 
collagen is deposited around the bronchioles and large blood vessels (Glynos et al 2018). 
PAS staining allows visualization of the blood air barrier, an important measurement in 
the capacity of the lungs to conduct adequate gas exchange (Fig 1) (Wawryk-Gawda et al 
2020). The barrier was thickened in both cigarette and ENDS groups (Fig 1) (Wawryk-
Gawda et al 2020). There was also elastolysis, which is the disruption of elastic fibers, 
found in both groups (Fig 2) (Wawryk-Gawda et al 2020).  
Cigarette exposed groups had irregularity of alveolar lumen, emphysema, 
intrabronchial mucus, and hemorrhage into the alveolar lumen (Fig 1) (Wawryk-Gawda 
et al 2020). The cigarette group had increased optical density, meaning that there was 




Figure 1. Histological structure of lungs exposed to cigarette smoke, evap and air. 
Group C, the control group, displayed the normal arraignment of collagen fibers around 
bronchioles. Group A, the ENDS group, displayed hyperemia and erythrocyte, 
eosinophil, and mononuclear cell infiltration (black arrows). Thicker alveolar septa due to 
increased collagen deposition, and collagen deposition in the peribronchiolar area was 
observed. Group B, the cigarette group, displayed hemorrhage (red arrow), infiltration of 
macrophages (green and black arrows), increased thickness of alveolar septa due to 
increased collagen deposition, and intrabronchiolar hemorrhage and mucus deposition 
(blue arrow). Hematoxylin and Eosin stain. Magnification at x100 or x400. (adapted from 




Figure 2. Cellular view of lungs exposed to cigarette smoke, evap and air. Group C, 
the control group, exhibited typical alveoli, a single myofibroblast with positive 
expression of α-SMA, and orcein staining displayed typical elastic fiber growth (green 
arrow). Group A, the ENDS group, and Group B, the cigarette group, had thicker 
basement membrane (black arrows), vacuole formation inside cells within the alveolar 
septa, increased number of α-SMA positive blood vessels (red arrows) and 
myofibroblasts (blue arrows). Disordered, sporadic and thicker elastic fiber growth was 
also observed (green arrows). SMA, smooth muscle actin stain. Magnification at x400 or 





ENDS groups had increased eosinophil and monocyte infiltration when compared 
to cigarette and control groups, thicker septa, and intrabronchial red blood cells (Fig 1) 
(Wawryk-Gawda et al 2020). The increased collagen deposition accounts for the 
thickened septa seen in ENDS (Glynos et al 2018). Smooth muscle alpha actin is an 
immuno histochemical stain that stains for myofibroblasts, cells that are activated for 
wound healing and participate in collagen deposition (Fig 2) (Wawryk-Gawda et al 
2020). cigarette vapor groups had increased myofibroblast activation with 20 per slide, 
ENDS had less at 17 per slide and the control group had one (Wawryk-Gawda et al 
2020). 
The damage caused by cigarette smoking is more severe with emphysema and 
fibrosis present. However, there are significant changes brought on by ENDS usage as 
well and makes the case that ENDS usage is not without harm. 
 
Inflammation  
Inflammation is a response to injury by the body. This allows for greater blood flow to 
the affected area, allowing immune cells to migrate and help in the repair process (Chen 
et al 2017). Cigarette and ENDS usage causes inflammation by directly harming cells 
with toxic compounds and their downstream metabolites, increasing the expression of 




Markers of Inflammation 
 
Inflammation in the body can be ascertained through monitoring levels of various 
chemicals in the body. C-reactive Protein, fractional exhaled nitric oxide (FeNO), 
thioredoxin, matrix metalloproteinase 9 (MMP9) and pro-inflammatory cytokines all 
increase locally when inflammation is present (Riedel et al 2018, Tibuakku et al 2017, 
Varvadas et al 2012). The number of macrophages and lymphocytes also increase locally 
under inflammation and can be used to determine if inflammation is present (Song et al 
2020). Soluble ICAM (sICAM) and pentraxin are a few of the systemic indicators of 
inflammation (Sussan et al 2015, Tibuakku et al 2017).  
Cigarette users caused increased macrophage and lymphocyte infiltration when 
compared to never users (Song et al 2020, Liu et al 2011). Cigarette users also had 
increased levels of C-reactive Protein and sICAM when compared to ENDS users and 
never users (Tibuakku et al 2017, Liu et al 2011). Levels of thioredoxin and MMP9 for 
cigarette users were elevated when compared to non-smokers (Riedel et al 2018). 
A study by Chatterjee found that C-reactive Protein levels of individuals who 
used ENDS were significantly elevated at 30 min to 4 hours post inhalation (Chatterjee et 
al 2019). The peak for C-reactive Protein levels was at 30 minutes to 1-hour post vaping 
(Chatterjee et al 2019). sICAM was increased 30 min to 240 after and returned to 
baseline at 6 hours (Chatterjee et al 2019). Levels of thioredoxin and MMP9 for ENDS 
users were elevated when compared to non-smokers and similar to cigarette users (Riedel 
et al 2018). Recruitment of macrophages and lymphocytes to the lungs of ENDS users 
were higher than control but lower when compared to cigarette smokers (Song et al 
 
18 
2020). Levels of dipeptidyl peptidase-4 an enzyme that modulates macrophage and T cell 
action was elevated 1.7-fold after vaping. Dipeptidyl peptidase-4 is linked to T cell 
recruitment and T cell-mediated inflammation (Crotty Alexander et al 2018). A study by 
Schweitzer found that the oxidative stress markers in BAL were increased 10 to 15% 
after ENDS use when compared to controls after a brief exposure (Schweitzer et al 2015). 
A study conducted by Vardavas found that after a single puff of an ENDS, FeNO was 
decreased by 16% with no change in controls (Varvadas et al 2012). However, when 
looking at longer-term ENDS users, on average 15 months of use, FeNO was decreased 
but not significantly suggesting a temporary change (Meo et al 2019). Mice exposed to 
evap for an hour daily for 14 weeks exhibited a significant increase in serum pentraxin 
(Sussan et al 2015).  
This shows that ENDS use causes inflammation in the lungs and systemically. 
Although the levels of these markers are lower than cigarettes users, they are significantly 
increased when compared to never users.  
 
Pro-Inflammatory cytokines 
Pro-inflammatory cytokines are chemical signals that are sent out in response to 
injury by tissue cells, and immune cells. Cigarette users had increased serum levels of IL-
1β, IL-2, IL-6, IL-8, IFNγ when compared with never users and ENDS users (Song et al 
2020, Tibuakuu et al 2017). A study by Glynos found that after 3 days of ENDS and 
cigarette exposure mice had increased levels of IL-1β and IL-6 but after 4 weeks of 
exposure, only the cigarette group had significantly increased levels (Glynos et al 2018). 
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Cigarette and ENDS exposed epithelial cells had increased secretion of IL-8 although 
cigarette exposed cells had significantly higher levels of secretion (Herr et al 2020). Cells 
grown at air liquid interfaces (ALI) mimic the environment of the lungs and had 
increased secretion of IL-8 for both cigarette smoke and evap, the levels of secretion 
were similar for both exposures (Herr et al 2020, Garcia-Acros et al 2016).  
ENDS users had increased levels of IL-1β, IL-6, and IFNγ when compared to 
never users (Song et al 2020). Small airway epithelial cells from mice that were briefly 
exposed to evap without nicotine had increased 1L-6 level for up to 24 hours after 
exposure (Gellatly et al 2020). Evap with nicotine did not cause a similar increase 
(Gellatly et al 2020). This could be due to the immune suppressive effects of nicotine 
(Gellatly et al 2020). Human bronchial epithelial cells exposed to evap had increased 
expression of IL-6, 24 hours, and 48 hours after exposure (Wu et al 2014).  
 Cigarette use causes increased and sustained secretion of IL-6 and IL-1β when 
compared to ENDS use (Glynos et al 2018, Herr et al 2020). However, ENDS use causes 
a significant increase in other proinflammatory cytokines when compared to controls and 
similar levels of IL-8 when compared to cigarette use (Sussan et al 2015, Herr et al 
2020). Although the effects of ENDS use are not as long lasting, the increases they cause 
are significant. 
 
Reactive Oxygen Species 
Reactive Oxygen Species (ROS) are molecules formed by the partial reduction of 
oxygen and consist of radical and non-radical species. They are produced by the body 
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under normal conditions from oxidative metabolism and are neutralized by antioxidants. 
However, when there is a large influx of ROS species or an increase in ROS production 
the balance of ROS and antiROS species shifts causing oxidative stress. Cigarette smoke 
is known to contain 10^14 free radicals and evap contains 7*1011 free radicals (Sussan et 
al 2015). ROS levels intracellularly after exposure to cigarette smoke and evap were 
increased and comparable in normal human bronchial epithelial cells (Ganapathy et al 
2017). ROS species are especially hazardous as they can cause damage to nucleic acids, 
proteins, and lipids (Khojah et al 2019). The damage they cause and the signaling 
pathways they are involved in have been implicated in carcinogenesis, aging, and many 
other diseases (Khojah et al 2019).  
Cigarette smoke is known to generate oxidants that start the redox cycle creating 
more ROS (Khojah et al 2019). These increases shift the antioxidant/oxidant balance 
which can be seen in a dose-dependent decrease in vitamin C and E because of increased 
lipid peroxidation (Khojah et al 2019). Cigarette smoke also caused an increase in the 
oxidative stress markers malondialdehyde and protein carbonylation three days to 4 
weeks after cigarette usage (Glynos et al 2018). The same was found for the levels of 
oxidative stress markers in BAL fluid (Glynos et al 2018). The increased influx of ROS 
affects the barrier function of the lungs. Cigarette smoke have been shown to increase 
endothelial cell monolayer permeability using ROS to activate signaling pathways that 
lead to a decreased lung endothelial barrier function and oxidant-induced injury to focal 
adhesion contacts, adherens junctions, and actin fibers (Shweitzer et al 2015, Rounds et al 
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2020). This increase allows for further influx of toxins contributing to the inflammatory 
state.  
The amount of ROS generated by ENDS is dependent on the ratio of PG to VG 
with VG creating more ROS (Sussan et al 2015). The amount of nicotine or type of 
flavoring used does not affect the amount of ROS generated as they originate from the 
solvent used (Sussan et al 2015). ROS generation from 4th generation vapes, supra ohm 
and sub-Ohm devices, is comparable to ROS levels in Cigarette smoke (Haddad et al 
2019). The toxins also cause an increase in endogenous ROS production. A study by 
Glynos found that oxidative stress markers malondialdehyde and protein carbonylation 
were increased after 3 days of ENDS use and cigarette usage and at the 4-week mark was 
increased for cigarette use and evap without nicotine and with flavoring agents in lung 
tissue (Glynos et al 2018). The same was found for the levels of oxidative stress markers 
in BAL fluid (Glynos et al 2018).  
Evap is known to cause an increase in ROS production in endothelial cells (EC) 
of the lungs thirty minutes to four hours after ENDS use (Chatterjee et al 2019). Nitric 
oxide (NO), an indicator of vascular health, significantly decreased 30 min to 120 min 
after vaping and was lower for 6 hours (Chatterjee et al 2019). A major source of this 
increase is NADPH oxidase 2 found in EC (Chatterjee et al 2019). Nitric oxide levels are 
significantly decreased after ENDS use and is thought to be partially attributed to an 
interaction between NO and ROS to form peroxynitrite, a ROS that is a downstream 
metabolite of NO (Chatterjee et al 2019). A decreased amount of NO affects endothelial 
cells and is thought to be an instigator of the increased ROS production (Chatterjee et al 
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2019). Endothelial dysfunction creates a loss of barrier integrity and decreased 
proliferation, which has been noted after ENDS use and cigarette use (Rounds et al 
2020). In evap acrolein, PG and glycerol play a role in this barrier disruption (Schweitzer 
et al 2015). Short-term exposure to evap causes decreases in tight junction proteins 
accounting for the decreased barrier function (Rounds et al 2015). The increased 
permeability causes a greater influx of antigens and external factors increasing 
inflammation and oxidative stress, which in turn increases permeability (Crotty 
Alexander et al 2018). These effects are evident in the increased number of pneumocytes, 
and cell-free protein seen in broncho alveolar lavage (BAL) samples after ENDS 
exposure (Crotty Alexander et al 2018, Lim et al 2014, Glynos et al 2018). The loss of 
barrier integrity can occur in brief exposures, and inflammation and oxidative stress are 
seen after brief vaping sessions (Crotty Alexander et al 2018).  
Although cigarette smoke causes increased contact with ROS species compared to 
older generation ENDS, newer generation devices have the potential to exert similar 
levels of exposure. Even with older generations devices, increases in oxidative stress 
markers and decreased barrier integrity are noted at lower levels when compared to 
cigarette use.  
 
Immune system  
The immune system in the lungs is built on cooperation between stromal cells, 
alveolar macrophages, and immune cells. This complex interplay helps maintain a 
healthy lung environment required for gas exchange to occur. Alveolar macrophages 
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conduct an integral part in this ecosystem by clearing debris on alveolar walls to allow 
for adequate lung function (Naeem et al 2020). This function is especially important for 
ENDS users and cigarette smokers as they are exposed to a large amount of particulate 
matter. 
A study showed that alveolar macrophages taken from eight non-smokers and 
exposed to evap experiencing nicotine-dependent cytotoxicity had increased apoptosis 
and necrosis (Scott et al 2018). Evap causes a decrease in the antimicrobial activity of 
alveolar macrophages in vitro (Hwang et al 2016). The antimicrobial activity of 
macrophages is dependent on ROS production, phagocytosis, and chemokine and 
cytokine release (Hwang et al 2016, Scott et al 2018, Ween et al 2017). Alveolar 
macrophages also influence the environment of the lungs by secreting cytokines. 
Cigarette smoke and evap are known to increase the release of IL-8 a proinflammatory 
cytokine and decrease the release of IL-6, IL-1β, MIP-1α, and TNFα by alveolar 
macrophages (Ween et al 2017). However, ENDS exposed alveolar macrophages have 
also shown increased release of proinflammatory cytokines IL-6, TNFα, and chemokines 
CXCL8, MCP-1, and proteases MMP-9 when compared to non-exposed controls (Scott 
et al 2018). The difference in these experiments could be due to different ENDS used and 
speak to the variability among devices.  
 A decreased ability to phagocytose bacteria is observed in macrophages exposed 
to cigarette smoke (Sussan et al 2015). The decreased phagocytosis capability is in part 
due to a 64% decrease in Toll-Like Receptor 2 which causes cigarette exposure (Ween et 
al 2017). ENDS exposed alveolar macrophages from human donors also had decreased 
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ability to phagocytose bacteria by 50% (Scott et al 2018). This could be due to a 9% 
decrease in the number of scavenger receptor SR-A1, which has been seen in evap 
exposed alveolar macrophages (Ween et al 2017). Toll-Like Receptors do not play a role 
in the decreased phagocytosis for evap exposed alveolar macrophages (Ween et al 2017). 
The use of N-acetyl cysteine, an antioxidant, helped reverse the adverse effects of evap 
on the phagocytosis and chemokine release of alveolar macrophages (Scott et al 2017). 
This suggests that the increased ROS from evap is a potential mechanism of inhibition of 
alveolar macrophage activity (Scott et al 2017). A PI3K inhibitor was also able to reverse 
these adverse effects on alveolar macrophages (Scott et al 2017). PI3K activation resulted 
in senescence and an apoptotic phenotype (Scott et al 2017). As a result of these 
inhibitions, alveolar macrophages that were exposed to evap were able to clear 53% less 
Staphylococcus aureus (SA) bacteria when compared to non-exposed controls (Hwang et 
al 2020). Alveolar macrophages also had significantly decreased clearance of 
Streptococcus pneumoniae when exposed to evap 4 hours after infection. (Sussan et al 
2015).  
Neutrophils are also affected by evap. Neutrophil antibacterial activity, which is 
dependent on ROS production, was decreased in a nicotine dose-dependent manner in 
vitro (Hwang et al 2020). Neutrophil chemotaxis was decreased by 4.2-fold, ROS 
production was decreased 42%, phagocytosis was decreased 48% and netosis (form of 
cell death that results in the release of loose chromatin to trap invading pathogens) was 
lowered by a factor of 3.5 when compared to controls (Corriden et al 2019). Neutrophil 
membrane fluidity was also altered by evap (Corrieden et al 2019). After daily inhalation 
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of evap for 1 month, there was decreased recruitment of neutrophils to sites of bacterial 
infection in mice (Correiden et al 2019). Under conditions of non-stress, a study by 
Reidel comparing the sputum of cigarette and ENDS smokers found elevated markers of 
neutrophil activation (Reidel et al 2018). Primary neutrophil granule proteins such as 
MOP, proteinase 3, and NET proteins were elevated significantly in ENDS users when 
compared with cigarette smokers and nonsmokers (Reidel et al 2018). The granule 
proteins are active pro-inflammatory agents and contributors to the pathogenesis of 
chronic lung diseases (Reidel et al 2019). There was no increase in the number of 
neutrophils for ENDS users when compared with cigarette users (Reidel et al 2019). This 
suggests that there is an altered activation state of neutrophils that increases their 
activation under normal conditions due to evap increasing the inflammatory state. 
However, exposure to ENDS also causes damage that renders the neutrophils with a 
decreased capability to fight invading microorganisms.  
Defensins are proteins that have an antibacterial activity or are part of the mucus 
barrier and are secreted by airway epithelial cells (Reidel et al 2018). Cigarette smokers 
had increased levels of these proteins such as DMBT1, trefoil factor 3, lactoferrin, and 
LYSC (Reidel et al 2018). Interestingly levels of DMBT1 and LYSC were significantly 
decreased in ENDS users when compared to non-smokers (Reidel et al 2018). Human 
bronchial epithelial cells exposed from non-smokers to ENDS vapor had decreased 
expression of SPLUNC1, another defensin (Wu et al 2014).  
ENDS use causes decreased antimicrobial activity of alveolar macrophages when 
compared to cigarette smoke. Cigarette use and ENDS use causes increased levels of 
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neutrophil activation under normal conditions and decreased levels of activation when 
exposed to pathogens when compared to cigarette use. ENDS use also causes decreased 
levels of defensin proteins production when compared to cigarette use. These changes 
show that the immune system appears to be more compromised in ENDS users when 
compared to cigarette smokers.  
 
Bacterial/Viral Increase 
The toxins found in cigarette smoke increase the risk for bacterial and viral 
infections (Miyashita et al 2018, Jiang et al 2020). Cigarette smokers are at a fourfold 
increased risk for pneumococcal disease when compared with those that do not smoke 
(Miyashita et al 2018). Streptococcus pneumoniae uses platelet activating factor receptors 
(PAFR) for internalization and cigarette smoke causes an increase in expression of this 
receptor 1 hour to 4 days after use (Grigg et al 2012). PAFR expression in control users 
never increased above the positive threshold (Grigg et al 2012). This also caused an 
increase in Streptococcus pneumoniae adhesion when compared to controls (Grigg et al 
2012). Cigarette smoke did not cause an increase in bacterial burden in mice when 
compared to controls (Shen et al 2016). Cigarette smoke exposed mice experienced 40% 
mortality when exposed to Streptococcus pneumoniae whereas control mice did not 
experience any death (Shen et al 2016). When cigarette smoke was stopped the mice did 
not experience any deaths (Shen et al 2016). The cigarette smoke exposed mice had 
increased weight loss when compared to controls (Shen et al 2016). Cigarette smoke is 
known to increase the risk of viral respiratory diseases (Jiang et al 2020). The risk of 
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death from influenza is 7.08 greater than nonsmokers (Jiang et al 2020). Cigarette 
smokers also had increased viral load from influenza infections when compared to never 
smokers (Jiang et al 2020).  
After ENDS use the amount of PAFR increases for an hour in vitro (Miyashita et 
al 2018). This effect also carried over to humans as biopsy samples revealed increased 
PAFR (Miyashita et al 2018). Evap increased Streptococcus pneumoniae adhesion to 
airway epithelial cells in a dose and time-dependent manner (Miyashita et al 2018). Evap 
exposed Staphylococcus aureus (SA) bacteria had increased hydrophobicity allowing 
greater clinging to lung cells and increased invasion (Hwang et al 2016). Keratinocytes 
secrete an antimicrobial peptide LL-37 in cell walls and outside for defense (Hwang et al 
2016). The minimum inhibitory concentration for SA bacteria is 7 µM, but when exposed 
to evap it increases to 10 µM (Hwang et al 2016). Mice were infected with SA and ENDS 
exposed SA, all the SA infected mice survived. However, ENDS exposed SA killed 25% 
of infected mice and at day 4 and had 110x the bacterial load (Hwang et al 2016). ENDS 
exposure caused bacteria to induce virulence gene expression (Hwang et al 2016).  
Mice were exposed to evap or air and then to mouse adapted H1N1 influenza 
virus to study the effects of evap (Sussan et al 2015). On day 4 there was a significantly 
increased viral titer in the mice exposed to evap (Sussan et al 2015). Both groups of mice 
followed similar weight loss patterns until day 9 of infection, after which mice exposed to 
the air were able to recover (Sussan et al 2015). Mice exposed to evap had delayed 
recovery and kept losing weight until day 12 (Sussan et al 2015). Two mice died in the 
ENDS exposed group with no deaths in the air group (Sussan et al 2015). On day 8 there 
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was significantly increased total inflammatory cells and neutrophils in the ENDS group 
when compared to the air group (Sussan et al 2015). Overall evap increased mortality 
from 30% to 60% (Sussan et al 2015). Evap with nicotine and a tobacco flavoring agent 
also caused an increased viral load in human bronchial epithelial cells when exposed to 
HRV at 6 hours and 24 hours post-infection (Wu et al 2014).  
This shows that ENDS use has similar effects on bacterial and viral infections as 
cigarette smoke. Both increase the virulence of the invading pathogens seen in the 
increased load and mortality after infection. More research will need to be conducted to 
determine the real-world consequences of ENDS use on humans.  
 
Lung Function 
ENDS use not only alters the lung environment but also affects the respiratory 
functions of the lungs. Active cigarette smokers had significantly reduced forced 
expiratory ratio (FEV 1/ FVC) by 7% when compared to nonsmokers (Meo et al 2019). 
FVC is the total amount of air that a person can exhale with force and FEV 1 is the 
amount of air that a person can exhale with force in one second (Swanney et al 2008). 
The ratio between FEV1 and FVC can help determine if the lungs are experiencing 
restrictive or obstructive distress (Swanney et al 2008). Healthy smokers who used ENDS 
for 10 minutes had significantly decreased oxygen saturation, increased airway 
resistance, and decreased specific airway conductance (Palamidas et al 2017). Mice 
exposed to evap without nicotine for three days had increased airway resistance, tissue 
elasticity, and decreased static compliance when compared to mice exposed to cigarette 
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smoke and air (Glynos et al 2018). After three weeks the results were reversed and only 
mice exposed to cigarette smoke had altered values (Glynos et al 2018). Mice also had 
increased airway hypersensitivity when exposed to cigarette smoke and evap containing 
nicotine and flavoring agents after three days (Glynos et al 2018). 
ENDS users who had smoked on average for 15 months were found to have 
significantly decreased FEV1, FEV1/FVC, forced expiratory flow 25% (FEF 25%), FEF 
50%, FEF 75%, FEF 25%-75%, and FEF 75%-25% when compared to users who did not 
smoke (Meo et al 2019). FEF is the flow rate of exhaled air at different percentages of 
FVC (Perillo et al 2004). FEV1/FVC was decreased by 6% (Meo et al 2019). There was 
no difference in Forced Vital Capacity (FVC) (Meo et al 2019). These reduced 
parameters suggest that there is peripheral airway obstruction and impairment brought 
about by ENDS use (Meo et al 2019). Never users who used ENDS for 10 min also had 
increased airway resistance and decreased specific airway conductance (Palamidas et al 
2017). Impulse oscillometry system, a non-invasive test of pulmonary function found 
increased airway impedance, increased lung resistance, and increased peripheral 
pulmonary resistance (Vardavas et al 2012). Peripheral flow resistance also increased 
18% after just 5 min of use (Vardavas et al 2012).  There is an increased impact on the 
peripheral airways when compared to the central airways for ENDS users (Varvadas et al 
2012).  
These experiments show that ENDS use may have similar effects on lung function 
when compared to cigarette use. Although the effects of cigarette smoke last longer, the 
decrease in FEV1/FVC between ENDS and cigarette use is not large. These experiments 
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were conducted on earlier generation of ENDS, potentially displaying lower levels of 
damage when compared to later generation devices. 
Mucociliary Function 
Mucociliary clearance (MCC) is essential to clear particulate matter that enters 
the lungs and of increased importance for smokers. Healthy maintenance of mucus 
secretion and cilia are necessary for proper MCC. Decrease in cilia beat frequency and 
alterations in mucin ratio and production have been seen when cells from many species 
are exposed to cigarette smoke and evap (Garcia-Acros et al 2016).  
Exposure to cigarette smoke caused a decrease in cilia beat frequency by 40% 1 
min after and recovered to baseline levels 20 min after (Carson et al 2017). An hour after 
exposure cilia beat frequency was increased by 19% in evap exposed cells and 15% by 
cigarette smoke-exposed cells (Carson et al 2017). Histological examination of cells 
exposed to cigarette smoke revealed matted and coalesced cilia due to hypersecretion, 
and secretory material permeated throughout (Fig 4) (Carson et al 2017). Cigarette smoke 
also caused decreased cilia length (Palazolo et al 2017). 
Exposure to evap (2.4% nicotine) caused a decrease in cilia beat frequency 33% 1 
min after and recovered to baseline levels 20 min after (Carson et al 2017). An hour after 
exposure cilia beat frequency was increased by 19% in evap exposed cells (Carson et al 
2017). Mice exposed to evap (2.4% nicotine) for 3 weeks had significantly blunted MCC 
(Laube et al 2017). Evap with 20 mg/ml nicotine caused a 50% decrease in MCC in 
sheep exposed to evap when compared to controls (Chung et al 2019). Nicotine-




Figure 3. Scanning Electron Microscopy (SEM) image of a fully differentiated 
ALI culture of human nasal epithelium exposed to air, evap and cigarette 
smoke.  (A) SEM image of a fully differentiated ALI culture of human nasal 
epithelium exposed to air (control group). The cilia are well-ordered, and the 
secretions of secretory cells is limited to their luminal borders (arrows). (B) SEM 
image of a fully differentiated ALI culture of human nasal epithelium exposed to 
cigarette smoke. Cilia are clumped toghether and there is increased secretory 
products and globular components of secretions that penetrate further into the 
ciliary bed. (C) SEM image of an ALI culture of human nasal epithelium exposed to 
evap. There is increased secretory products above the ciliary bed and less 
penetration of this material inside the ciliary bed when compared to cigarette 
smoke exposed cells. (D) High-magnification SEM image of the ciliary bed from evap 
exposed cell culture displays fibrillar material creating a mesh by attaching to the 




exposure of cells to evap (36 mg/ml nicotine) (Chung et al 2019). This is attributed to 
decreased ion transport by CFTR and BK channels leading to a decreased periciliary 
liquid layer (Chung et al 2019). Cells exposed to evap also had increased mucus viscosity 
with 3.5% mucus solids, this value is close to mucus samples of patients with bronchitis 
(Chung et al 2019). Cells exposed to evap had a fibrillar mesh material, and less 
permeated secretory material (fig 3) (Palazolo et al 2017). Normal cells only have 
material associated with the luminal border of secretory cells (fig 4) (Palazolo et al 2017). 
One day exposure of human bronchial epithelial cells to sub-ohm evap caused 
disorganized cilia (Noel et al 2020). Decreased CFTR conductance causing dehydrated 
mucus was also noticed in nHBE cells exposed to evap (Garcia-Acros et al 2016). 
 Cigarette smoke and evap cause decreased mucociliary clearance. Cigarette 
smoke causes decreased MCC when compared to evap. However, evap causes a 
significant decrease in MCC when compared to controls.  
 
DNA Damage 
DNA damage from cigarette and ENDS occur from adduct formation and ROS 
injury (Ganapathy et al 2017, Lee et al 2018). Studies have shown that low levels of 
cigarette smoke cause significant DNA damage to oral and lung epithelial cells 
(Ganapathy et al 2017). Two major adducts in cigarette smoke are 1, N2-propano-dG 
(PdG) and O6-methyl-deoxyguanosine (O6-medG). PdG is created by nitrosamine 
breakdown and reactive aldehydes, like formaldehyde, acetaldehyde, and acrolein (Lee et 
al 2018). This makes PdG the major cause of nitrosamine carcinogens (Lee et al 2018). 
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O6-medG is an adduct to DNA induced by oxidative stress and nitrosamines and their 
downstream metabolites (Lee et al 2018). O6-medG causes GC to TA transversions in 
DNA (Ganapathy et al 2017, Lee et al 2018). 
 Cells exposed to evap for two weeks had more O6-medG when compared to cells 
exposed to cigarette smoke for two weeks (Ganapathy et al 2017). After 1 hour exposure 
to evap, a significant increase in DNA damage was observed in human epithelial normal 
bronchial cells (Ganapathy et al 2017). Greater than 10 puffs of ENDS caused DNA 
damage to both the transcribed strand and nontranscribed strand of the p53 gene in the 
cells however, the levels of damage were lower when compared to cigarette smoke 
(Ganapathy et al 2017). After a two-week long exposure to evap there was significant 
damage to both p53 strands, but it was still at a lower level than cigarette smoke 
(Ganapathy et al 2017). This could be due to decreased DNA repair mechanisms for 
oxidative stress found in evap exposed cells (Queimado et al 2018).  
These studies show that ENDS use causes significant DNA damage although at 
lower levels when compared to cigarette use. However, ENDS use does cause an increase 
in O6-medG DNA adduct when compared to cigarette use.  
DNA Repair 
DNA repair is important for normal cell function and especially under times of 
stress, and increased toxin load. Nucleotide excision repair fixes PdG lesions and base 
excision repair fixes O6-medG (Lee et al 2018). Excision repair cross-complementation 
group (ERCC1) is a nucleotide excision repair protein essential for bulky DNA damage 
and 8-oxoguanine-DNA glycosylase (OGG1) is an essential base excision repair protein 
 
34 
used for repairing oxidative stress-related DNA lesions (Ganapathy et al 2017). OGG1 
and ERCC1 are rate-limiting steps for both nucleotide excision repair and base excision 
repair (Lee et al 2018). Cigarette smoke causes significant increases in the expression of 
ERCC1 whereas ENDS exposure only significantly increased expression in one out of 
two cell lines (Ganapathy et al 2017). Cigarette smoke caused a decrease in XPC, another 
nucleotide excision repair protein in lung tissue of mice (Lee et al 2018). However, 
exposure to evap caused a significant decrease in OGG1 expression in both cell lines and 
only one cell line in cells exposed to cigarette smoke (Ganapathy et al 2017). This shows 




Evap and cigarette smoke cause changes in the transcription of many genes. 
Analysis of cells treated with evap and cigarette smoke 24 hours after exposure show that 
cigarette smoke activates a different set of genes than ENDS or control (Herr et al 2020). 
When cigarette smoke was analyzed 16 genes were found to be down-regulated and 33 
were upregulated 1-hour post-exposure (Shen et al 2016). The upregulated genes 
included genes that controlled cell cycle regulation, apoptosis, response to organic 
substance, and hypoxia genes (Shen et al 2016). The downregulated genes were due to 
toxins found in cigarette smoke (Shen et al 2016). At 4 hours, 95% of dysregulated genes 
were upregulated and the majority were a response to stress and DNA damage (Shen et al 
2016). At 24 hours, 88 out of 91 genes were upregulated and were involved with MAPK 
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signaling, apoptosis, and response to hypoxia (Shen et al 2016). Many of these genes 
were upregulated at earlier time points and show the long-lasting toxic effects of cigarette 
smoke. Cigarette smoke also upregulated genes regulated by REL-A and JUN 
transcription factors (Herr et al 2020). These genes are responsible for proinflammatory 
cascades (Herr et al 2020). Cigarette smoke also caused activation of genes related to 
cytochrome P450, CYP1A1, involved in the metabolism of PAHs (Herr et al 2020). A 
28-fold increase in CYP1A1 activation was observed in cigarette smoke exposed samples 
when compared to evap and 30-fold increase in activation when compared to control 
(Herr et al 2020). A 2.3-fold increase in glutathione peroxidase 2, an antioxidant, was 
also observed when compared to evap, and evap had a 1.3-fold increase when compared 
to controls (Herr et al 2020).  
Evap exposed primary human bronchial epithelial cells had different gene 
expression than cigarette smoke but were more similar to control cells (Herr et al 2020). 
A study by Shen looked at the effects of cigarette smoke and evap on the transcriptome of 
human bronchial epithelial cells after 1 hour, 4 hours, and 24 hours after exposure to the 
selected vapours (Shen et al 2016). Evap caused downregulation of 43 genes and up reg 
of 13 genes 1 hour after exposure (Shen et al 2016). The genes that were downregulated 
were cell cycle, response to hypoxia, response to an organic substance, apoptosis, and 
acute inflammatory response genes (Shen et al 2016). Upregulated genes included 
cytochrome p450 and genes related to nicotine processing (Shen et al 2016). The number 
of genes differently regulated decreased at 4 hours and more at 24. By 24 hours most of 
the expression profiles had returned to near baseline levels except for genes regulating 
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cell cycle control and apoptosis (Shen et al 2016). However, most genes that were 
dysregulated became upregulated at the 4 hour and 24-hour time points. At these time 
points, MAPK signaling pathways genes such as matrix metalloprotease 9 were 
upregulated (Shen et al 2016). Cells exposed to evap were the only cells that had altered 
lipid metabolism pathways (Shen et al 2016). When compared to cigarette smoke, evap 
have similar immediate effects as they activate similar pathways: response to hypoxia, 
cell cycle regulation, and inflammation although at lower levels (Shen et al 2016). The 
changes induced by evap are not as long lasting as cigarette smoke and cigarette smoke 
causes increased dysfunction of gene expression.  
 
Health Risks  
This section will go over the known health diseases from ENDS use and known risks 
from usage.  
 
Unique Reports: EVALI  
EVALI (E-cigarette, or Vaping, Product Use Associated Lung Injury) is a form of 
acute lung injury with varying pathologic findings. EVALI cases started to increase in 
2018 reaching their peak in 2019 (Jonas et al 2020). As of December 2019, there were 
2807 hospitalizations nationwide and 68 deaths (Jonas et al 2020). The diagnosis was 
difficult and done by excluding other possibilities and required a multidisciplinary 
approach to combat. To qualify as EVALI, patients had to have used a vape product 
within 90 days of hospitalization, signs of pulmonary infiltrate, and not have any viral or 
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bacterial infection (Jonas et al 2020). A large percentage of patients had used THC vapes 
in addition to ENDS (Cherian et al 2020). Demographic analysis of the patients revealed 
that 78% were under 35 years of age with the median age ranging from 19-27 (Cherian et 
al 2020, Blount et al 2020).   
Patients usually presented with a gradual onset of respiratory symptoms, 
gastrointestinal distress, and constitutional symptoms over the period of days to weeks 
(Cherian et al 2020). On admittance, 48-50% of patients had oxygen saturation of below 
88% (Shinbasi et al 2020).  Radiologically patients had bilateral hazy ground glass 
opacities with subpleural sparing and diffuse alveolar damage (Cherian et al 2020, 
Shinbashi et al 2020). The opacities are signs of pulmonary infiltrate. Subpleural sparing 
means that the damage was not near the chest wall or the extremities of the lungs, as the 
cause was the vape aerosol. Patients had a large accumulation of lipid laden macrophages 
(foamy cells) and pneumocytes, largely consisting of neutrophils present in BAL samples 
(Cherian et al 2020). A large amount of lipid laden macrophages could be due to the high 
amount of glycerin present in evap (Cherian et al 2020). Inflammation was common and 
evidenced by elevated C-reactive protein (CRP) and erythrocyte sedimentation rate FeNO 
in patient’s serum (Shinbashi et al 2020, Jonas et al 2020). Patient biopsies and 
pathological studies found nonspecific acute lung injury patterns consisting of organizing 
pneumonia and diffuse alveolar damage (Shinbashi et al 2020, Jonas et al 2020). 
Individual patients had varying histopathologic features which included interstitial 
pneumonia, hyaline membranes, interstitial edema and fibrinous exudates. For treatment, 
95% of patients required hospitalization, and of those 27% were intubated. Patients 
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improved significantly after cessation of vaping and most (84%) required steroids (Jonas 
et al 2020). Mean discharge time was 7.5 days and most had complete resolution at two 
weeks.  
Finding the cause of this outbreak has been difficult mainly due to a large amount 
of chemicals present in the vape solutions. Some studies point to vitamin E acetate, which 
was found in 94% of BAL specimens in hospitalized patients (Jonas et al 2020). Vitamin 
E acetate was used as an additive to the vape solutions to dilute them because of its easy 
accessibility (Blount et al 2020). The exact mechanisms of lung injury that vitamin E 
acetate employs are unknown; however, studies show that it could play a role in the 
disruption of surfactant production (Jonas et al 2020).  The frequency of these cases has 
dropped significantly since 2019 due to actions by the FDA and increased vigilance on 
ENDS regulations (Blount et al 2020). More stringent regulation of the sale and 
purchasing of ENDS outside of the US is one of the reasons for the relatively few EVALI 
cases seen abroad (Shinbashi et al 2020). EVALI represents an extreme case of acute 
lung damage that vaping can cause. Although most patients recovered completely, the 
long-term effects of EVALI remain to be determined.  
 
Concern for Cancer Risk  
Lung cancer is a devastating disease that is the leading cause of cancer deaths in 
the US (United States Surgeon General, 2014). In 2020 there are expected to be 228,820 
new cases of lung cancer with 135,720 deaths (Siegel et al 2020). The method for 
cigarette smoke to cause cancer has been laid out by the surgeon general report and can 
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be seen in Fig 4 (United States Surgeon General, 2014). Regular cigarette smoking 
causes uptake of carcinogens which become metabolically activated and cause DNA 
damage (United States Surgeon General, 2014). Over time causing mutations in 
oncogenes and tumor-suppressing genes. Simultaneously, nicotine binding to nicotinic 
acetylcholine receptors, and other toxicants binding to receptors causes activation of 
protein kinases A, B, C, and other changes (United States Surgeon General, 2014). This 
along with epigenetic changes causes loss of normal growth and cancer.  
 
Figure 4 Pathway for causation of cancer by carcinogens in tobacco smoke (adapted 
from United States Surgeon General 2014). 
 
ENDS and cigarette use both cause the human body to encounter significant 
quantities of toxic and carcinogenic substances. Even though ENDS contains 
significantly lower levels of all major cigarette toxicants, they are significantly increased 
when compared to never smokers. However, the newer generation of vaping devices 
capable of sub-ohm and supra ohm vaping produces toxic substances at levels similar to 
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those in cigarette smoke, especially levels of ROS and carbonyl compounds (Noel et al 
2020). More studies will need to be completed on these newer generation vapes to 
understand the impact of the increased toxic substances. The enzymes that help 
metabolize these toxic substances and activate some have also been increased under 
ENDS use. Studies done on rats showed an increase in CYP1A1 (a XME that activates 
PAH), CYP2B1/2 (an XME that activates halogenated hydrocarbons), CYP2CII (an 
XME that metabolizes nitrosamines), and CYP3A (an XME that activates also activates 
nitrosamines) (Canistro et al 2017). These enzymes also overproduce ROS and is a 
documented way of how they contribute to cancer formation (Canistro et al 2017).  
The increase of endogenous ROS production increased exogenous ROS, and 
induction of an inflammatory state causes impaired redox homeostasis. Inflammatory 
environments increase the risk for cancer, as the increased cell turnover and DNA 
damage increase the formation of mutations. Cytotoxicity from evap exposure has been 
seen in multiple studies and contributes directly to an increased cell turnover rate (Noel et 
al 2020). The oxidative stress along with nitrosamine metabolites cause DNA adducts 
(Lee et al 2017). Exposure to evap has been shown to cause significant DNA adduct 
formation in cells (Lee et al 2017, Ganapathy et al 2020). Even causing increased O6-
medG levels when compared to cigarette exposure (Ganapathy et al 2020). Adequate 
DNA repair mechanisms would be able to cope with the increased DNA damage, 
however, evap also causes significant damage to BER and NER mechanisms (Lee et al 
2017, Ganapathy et al 2020). As a result, increased frameshift, and base substitution 
mutations were noted in evap exposed rats (Canitro et al 2017). 
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 P53 the guardian of the genome, also had significant DNA damage after exposure 
to evap (Ganapathy et al 2020). P53 plays a critical regulatory role causing apoptosis of 
cells that have increased DNA damage, the last step to prevent further propagation of a 
mutated cell (Ozaki et al 2011). Over 50% of all cancers contain a mutation in the p53 
gene (Ozaki et al 2011). Studies using older 2nd and 3rd generation devices with eliquid 
that contained nicotine at 18 mg/ml found increased PKC and ERK signaling via α7 
nicotinic receptors similar to cigarette smoke (Garcia-acros et al 2016). 
With all these similarities in activation, the risk of ENDS use causing cancer is 
significant especially as more users start to utilize newer generation devices. With the 
ability to deliver nicotine and ROS and carbonyls in levels similar to cigarettes the risk is 
only going to increase. 
 
Chronic Obstructive Pulmonary Disorder (COPD) 
COPD is the fourth leading cause of death in the US and the third worldwide 
(Boukhenouna et al 2018). COPD is a disease caused by emphysematous destruction of 
elastic fibers and increased fibrous deposition from chronic tissue repair processes (Hogg 
et al 2020). Normal wound repair occurs when adequate time is given between injuries. 
The chronic inflammatory state and continual tissue destruction induced by cigarettes 
smoking lead to abnormal wound repair and scar formation (Hogg et al 2020). COPD is 
diagnosed by measuring the FEV1/FVC. If that value falls below 70% COPD is assigned 
(Hogg et al 2020). Increased resistance to flow in the small airways and decreased elastic 
recoil of the lungs from the destruction of elastic fibers account for the decrease in FEV1 
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(Meo et al 2019). The major risk factor for COPD is the inhalation of toxic particles and 
gases (Hogg et al 2020). Decreases in FEV1/FVC have been shown in ENDS users after 
vaping (Meo et al 2019). ENDS use causes increased mean airway resistance and 
decreased airway conductance in smokers with COPD and asthma when compared with 
healthy and never smokers (Palamidas et al 2017). 
Although emphysematous changes were not seen in histological samples when 
compared to those exposed to cigarette smoke, there was increased fibrous deposition and 
destruction of elastic fibers in samples exposed to evap (Wawryk-Gawda et al 2020). 
Increased ROS production seen with ENDS use is a hallmark of COPD (Boukhenouna et 
al 2018). The imbalance of redox homeostasis leads to oxidative stress that increases 
inflammation. Neutrophils are a key component in the progression of COPD through 
increased ROS production and release of matrix metalloproteinases that degrade the 
extracellular matrix including elastic fibers (Scott et al 2018, Boukhenouna et al 2018). 
Increased production and release of MMP-9 have been seen in samples exposed to evap 
at 2 weeks and 4 months post-exposure (Scott et al 2018, Garcia-acros et al 2016). 
Decreased mucociliary clearance and altered mucin ratios seen in the lungs of ENDS 
users are also associated with COPD formation (Chung et al 2019, Garcia-acros et al 
2016).  
ENDS use has been associated with COPD, from data gathered from the 
Behavioral Risk Factor Surveillance System national survey data (Xie et al 2020). 
Analysis of that data showed an increased odds ratio for developing COPD for vapers 
who had never smoked when compared to nonusers (Xie et al 2020). Although the 
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association between cigarette smoking and COPD is stronger, this could be because 
vaping has not been around long enough and earlier generations of vapes were not as 
powerful (Xie et al 2020).  
 
Dual Product Use 
ENDS were meant as a method to help cigarette smokers quit. Interestingly, 
studies have shown that they can have the opposite effect leading to the use of both 
devices and dual use. In 2015, 59% of ENDS users were dual users (Chun et al 2017). A 
study by Smith looking at users from three different countries found that dual users had 
no difference in VOC and had lower amounts of 3 TSNAs, and two PAHs when 
compared with cigarette smokers (Smith et al 2020). This study found that toxic effects 
for dual users depended on the number of cigarettes smoked (Smith et al 2020). A study 
by Goniewicz found dual users had higher amounts of almost all toxic substances when 
compared with cigarette-only smokers (Goniewicz et al 2018). This study found that dual 
users had significantly higher amounts of 3 TSNAs, 5 PAHs, and 13 VOCs. Cigarette 
smokers had 23% decreased NNAL, 10% decreased acrolein and 15% decreased 
acrylonitrile when compared with dual users (Goniewicz et al 2018). This study also 
found that users who used ENDS multiple times during the week but not every day 
(someday ENDS) and someday cigarette smokers had decreased toxic compounds when 
compared to everyday ENDS and everyday cigarette dual users (Goniewicz et al 2018). 
In line with these findings, a study by Smith also found that biomarkers for toxic 
compounds were statistically similar for everyday ENDS and cigarette smokers and 
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everyday cigarette and someday ENDS smokers (Smith et al 2020). The toxicity for dual 
users follows cigarette usage. A cross-sectional longitudinal study conducted by Shabab 
found that nicotine intake, TSNA level, and VOC level were similar for dual users when 
compared to cigarette smokers. The toxic effects of dual use are found to be comparable 
or higher than cigarette smoke. 
 
CHAPTER 3: DISCUSSION 
 Cigarette use is associated with many diseases and adverse health effects. ENDS 
were made as an alternative to reduce exposure to these chemicals. As these devices are 
relatively new to the market and are constantly changing, there is not a large body of 
research to ascertain the negative health effects they can have. ENDS use causes the body 
to encounter significantly lower levels of most toxic chemicals encountered in cigarette 
smoke. However, these levels in ENDS are significantly higher when compared with 
never users. The toxins in evap cause visible alterations to the lung tissue, albeit at a 
lesser degree when compared to cigarette use. The emphysematous changes noted in 
cigarette smoke exposed samples are not seen in evap exposed samples, however 
destruction of elastic fibers is noted. The increased fibrous deposition and destruction of 
elastic fibers are hallmarks of respiratory diseases such as COPD, and pulmonary fibrotic 
diseases (Black et al 2008, Wilson et al 2009).  
 Chronic inflammation caused by the toxins in cigarette smoke contributes to the 
adverse health outcomes seen from cigarette use. ENDS use causes an increase in 
inflammatory markers such as CRP, sICAM, immune cells and the proinflammatory 
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cytokines; IL-1β and IL-6 when compared to never users. These values are lower when 
compared with cigarette use. Proinflammatory cytokines are an integral part of the 
inflammatory response and help perpetuate the inflammatory state. The effects of ENDS 
are also not as sustained with levels of proinflammatory cytokines and other 
inflammatory markers decreasing quicker than those of cigarette smoke exposed samples. 
Oxidative injury arising from a redox imbalance is another contributor to an 
inflammatory state. ROS species cause damage to nucleic acids, proteins, and lipids. 
cigarette smoke and evap contain high levels of these species and cause increased 
endogenous ROS production. Cigarette smoke causes increased oxidative stress markers 
when compared with evap from earlier ENDS generations. Evap causes increased 
oxidative stress markers when compared with never users. ROS species also cause a 
decrease in barrier integrity allowing greater influx of toxins prolonging the 
inflammatory state. More studies on prolonged ENDS use will be needed to determine if 
the increased levels of inflammation and oxidative stress when compared to never users 
will have lasting chronic effects.  
 Altered immune functions are noted in cigarette smokers and predisposes them to 
bacterial and viral infections. Evap and cigarette smoke cause a decrease in the 
antimicrobial activity of alveolar macrophages. The decreased ability to phagocytose 
bacteria is especially troubling as these macrophages clean up debris on alveolar surfaces 
to provide optimal gas exchange. Altered MCC that is seen in ENDS users, although 
lower than cigarette smokers will likely increase the load that the macrophages have to 
deal with. Neutrophils were affected more by ENDS when compared to cigarettes, 
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displaying increased activation under normal condition and decreased activation when 
fighting pathogens. Neutrophils are an important arm of the immune system and help in 
fighting off bacterial infections (Selders et al 2017). This crucial function is made even 
more important as evap causes an increase in the virulence of invading bacteria and 
viruses. A large cause of mortality from COPD is from exacerbations by viral and 
bacterial infections (Sussan et al 2015). The altered antibacterial ability of alveolar 
macrophages and neutrophils to fight these bacteria and increased virulence of the 
invading pathogens have the strong possibility to increase the mortality from COPD 
exacerbations.  
ENDS use causes similar changes in lung function parameters as cigarette 
smokers. Although the changes brought on by cigarette use lasts longer, there are 
significant changes in these parameters when compared to never users. The lowered 
FEV1/FVC is associated with COPD and other respiratory diseases.  
The damage that ENDS use causes to DNA and DNA repair mechanisms is 
significant when compared to never users. O6-medG adduct formation was greater in 
evap exposed cells than cigarette smoke exposed cells. Overall DNA damage was greater 
in cigarette smoke exposed samples; however, the effects were just as long lasting. The 
damage to repair mechanisms makes the impact of the damage caused worse and more 
significant. This increases the risk of mutations and contributes to increased cancer risk. 
Future studies can be aimed at understanding the effects of the newer generation 
of ENDS. More studies need to be done on the inflammatory effects of fourth generation 
ENDS that have ROS and carbonyl concentrations similar to cigarette smoke. These 
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increases can have a cause increased DNA adduct formation leading to increased 
mutation risk. The ability of these devices to carry increased amounts of nicotine at levels 
near and above cigarettes and thus their ability to create addiction to nicotine is another 
interesting place to study. 
 
CHAPTER 4: CONCLUSIONS  
ENDS have a myriad of configurations in terms of device capabilities and eliquid 
composition. This variety causes problems for standardized studies about the health 
effects that these devices can have. These studies are important as they allow for a 
glimpse into the possible health effects these devices can create. In terms of toxic 
chemicals, ENDS deliver significantly less PAHs, TSNAs, and VOCs when compared to 
cigarettes. Although later generation devices are becoming more capable of producing 
several toxic substances, mainly carbonyl compounds and ROS, at levels similar to 
cigarette smoke. The level of nicotine in these later generation devices has also 
approached and surpassed in a few cases the level of nicotine delivered in cigarettes. 
Nicotine is responsible for the addiction that cigarette and ENDS cause, and the reason 
for their continued use. These toxic compounds interact with the body and cause harm to 
the immune system, the genome, and lung function. ENDS use causes altered activation 
of the immune system and increases the virulence of invading pathogens. DNA repair 
mechanisms as well as the DNA itself also experience significant damage under ENDS 
use. Albeit at lower levels when compared to cigarette smoke. ENDS use causes 
significant inflammation and oxidative stress when compared to never users, but at lower 
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levels when compared to cigarette smokers. However, diseases such as EVALI, highlight 
the potential disastrous outcomes ENDS use can have. 
The full effects of ENDS on the body are not known, and with newer devices and 
eliquids being made each day, it is unlikely that they will. However, there is significant 
evidence that these devices are harmful to the human body and that continued use can 
have detrimental effects. With ENDS use still at low levels throughout the population, 
this allows the opportunity to act differently when compared with cigarette restrictions. 
Stronger restrictions are a reason why the EVALI epidemic did not cause many cases 
abroad. With use in adolescents, an especially vulnerable population, rising stronger 
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